AG-1478

CAT:
804-HY-13524-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
AG-1478 - image 1

AG-1478

  • Description :

    AG-1478 (Tyrphostin AG-1478) is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM. AG-1478 has antiviral effects against HCV and encephalomyocarditis virus (EMCV) .
  • Product Name Alternative :

    Tyrphostin AG-1478; NSC 693255
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    EGFR; HCV; Influenza Virus
  • Type :

    Reference compound
  • Related Pathways :

    Anti-infection; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
  • Applications :

    Cancer-Kinase/protease
  • Field of Research :

    Cancer; Infection; Metabolic Disease; Cardiovascular Disease
  • Assay Protocol :

    https://www.medchemexpress.com/ag-1478.html
  • Purity :

    99.57
  • Solubility :

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles :

    COC1=CC2=NC=NC(NC3=CC=CC(Cl)=C3)=C2C=C1OC
  • Molecular Formula :

    C16H14ClN3O2
  • Molecular Weight :

    315.75
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Bojko A, et al. The effect of tyrphostins AG494 and AG1478 on the autocrine growth regulation of A549 and DU145 cells. Folia Histochem Cytobiol. 2012 Jul 5;50 (2) :186-95.|[2]Li W, et al. EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice. Sci Rep. 2016 Apr 18;6:24580.|[3]Akhtar S, et al. Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo. PLoS One. 2015 Jul 13;10 (7) :e0132215.|[4]Dorobantu CM, et al. Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα. Antimicrob Agents Chemother. 2016 Sep 23;60 (10) :6402-6.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    No Development Reported
  • Isoform :

    EGFR/ErbB1/HER1
  • CAS Number :

    [153436-53-4]